Federal contractor profile

ACCORD BIOPHARMA, INC.

UEI M3PMHL5VML74CAGE 98XD1Company website ↗

Active

Overview

Legal name: ACCORD BIOPHARMA, INC.
Registered location: RALEIGH, NC, USA
Website: Company website ↗
Primary NAICS: 325412 — Pharmaceutical Preparation Manufacturing
Latest award activity: Sep 2, 2026

Read company summary

ACCORD BIOPHARMA, INC. is associated with UEI M3PMHL5VML74 and CAGE 98XD1 in public federal records. AcornBids currently links 3 prime awards totaling $19.4M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists RALEIGH, NC, USA.

At a glance

Lifetime prime obligations$19.4M

Prime awards3

Awards with future end dates1

Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name: ACCORD BIOPHARMA, INC.
UEI: M3PMHL5VML74
CAGE: 98XD1
Registered address: 8041 ARCO CORPORATE DR STE 200, RALEIGH, NC, 27617, USA
Registration status: Active
Primary NAICS: 325412 — Pharmaceutical Preparation Manufacturing
SAM activation: Jul 24, 2026
Initial registration: Jan 14, 2022
Entity start: Nov 21, 2014
SAM updated: Jul 24, 2026
Registration expires: Jul 23, 2027
Fiscal year end: Mar 31
Place of incorporation: DE, USA

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / description	Awarding agency	Obligations	Start date	End date
36E79725D0014NEW AWARD FOR PEGFILGRASTIM WITH COHERUS BIOSCIENCES, INC. ORDERING PERIOD IS APRIL 11, 2025, TO APRIL 10, 2026, WITH FOUR ONE-YEAR OPTIONS.	Department of Veterans Affairs	$27.6M	Apr 11, 2025	Not available
36F79723D003965 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD	Department of Veterans Affairs	$300.0K	Dec 15, 2022	Not available
75A50325C00002PEGFILGRASTIM 6MG/.06ML (INJ, SOLN, SYR OR AUTOINJECTOR) AND VMI	Department of Health and Human Services	$19.4M	Mar 19, 2025	Mar 18, 2030

Explore, filter and export all awards →Subcontracts Grants & subgrants

Upcoming positioning windows

Modeled recompete windows are estimates, not announced solicitations or guarantees.

PEGFILGRASTIM 6MG/.06ML (INJ, SOLN, SYR OR AUTOINJECTOR) AND VMI

Department of Health and Human Services$19.4M obligationsEnds Mar 18, 203045% recompete estimate

Registration, certifications & contacts

Registration evidence	Date
SAM updated	Jul 24, 2026
Source loaded	Sep 26, 2026
Initial registration	Jan 14, 2022
Entity start	Nov 21, 2014

Industry	Reported size status
325412 — Pharmaceutical Preparation Manufacturing	Not reported

Contact	Role	Published contact methods	Evidence	Source date
ALIESE M WARD	Government business	Contact method not published	SAM registration	Not available
PAUL PURDY	Alternate government business	Contact method not published	SAM registration	Not available
TARA BRODO	Electronic business	Contact method not published	SAM registration	Not available

Registered industries

325412 — Pharmaceutical Preparation Manufacturing

Registered products and services

6505 — Drugs and Biologicals

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source